ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
UAE Approves BioAros Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant move…
